Inovio Pharmaceuticals Inc (INO):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Inovio Pharmaceuticals Inc (INO) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7284
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Inovio Pharmaceuticals Inc (Inovio) is a biotechnology company that focuses on developing a portfolio of DNA immunotherapies and vaccines for the treatment and prevention of various cancers and infectious diseases. The company develops products based on its core SynCon DNA plasmid technology and electroporation delivery technology. It is advancing a preclinical and clinical stage product pipeline to fight cancers of the cervix, prostate, breast, bladder, head and neck, lung, and pancreas; and to protect against and eliminate infectious diseases such as HIV, hepatitis, Ebola, Zika virus and Middle East respiratory syndrome (MERS). Inovio is headquartered in Plymouth Meeting, Pennsylvania, the US.

Inovio Pharmaceuticals Inc (INO) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Inovio Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Inovio Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Inovio Pharmaceuticals Inc, Medical Equipment, Deal Details 10
Asset Purchase 10
Inovio Pharma Acquires Assets from Bioject Medical Technologies for USD5.5 Million 10
Equity Offering 11
Inovio Pharma Plans to Raise up to USD250 Million in Public Offering of Shares 11
Inovio Pharma Raises USD75 Million in Public Offering of Shares 12
Inovio Pharma Completes Public Offering Of Shares For US$63.3 Million 14
Inovio Pharmaceuticals Inc – Key Competitors 15
Inovio Pharmaceuticals Inc – Key Employees 16
Inovio Pharmaceuticals Inc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Aug 07, 2018: Inovio Pharmaceuticals reports 2018 second quarter financial results 19
May 09, 2018: Inovio Pharmaceuticals Reports 2018 First Quarter Financial Results 21
Mar 14, 2018: Inovio Pharmaceuticals Reports 2017 Fourth Quarter and Year End Financial Results 23
Nov 08, 2017: Inovio Pharmaceuticals Reports 2017 Third Quarter Financial Results 26
May 10, 2017: Inovio Pharmaceuticals Reports 2017 First Quarter Financial Results 29
Mar 15, 2017: Inovio Pharmaceuticals Reports 2016 Fourth Quarter and Year End Financial Results 31
Corporate Communications 34
May 24, 2018: Inovio Boosts Leadership Focused on Partnership and Grant Funding By Appointing Two New VPs for Business Development and R&D 34
Dec 06, 2017: Inovio Pharmaceuticals Appoints Wendy Yarno To its Board of Directors 35
Jun 28, 2017: Inovio Announces Leadership Appointments 36
Mar 21, 2017: George Bickerstaff Elected to Inovio’s Board of Directors 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Inovio Pharmaceuticals Inc, Medical Equipment, Key Facts, 2017 2
Inovio Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Inovio Pharmaceuticals Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Inovio Pharmaceuticals Inc, Deals By Market, 2012 to YTD 2018 8
Inovio Pharmaceuticals Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Inovio Pharma Acquires Assets from Bioject Medical Technologies for USD5.5 Million 10
Inovio Pharma Plans to Raise up to USD250 Million in Public Offering of Shares 11
Inovio Pharma Raises USD75 Million in Public Offering of Shares 12
Inovio Pharma Completes Public Offering Of Shares For US$63.3 Million 14
Inovio Pharmaceuticals Inc, Key Competitors 15
Inovio Pharmaceuticals Inc, Key Employees 16
Inovio Pharmaceuticals Inc, Subsidiaries 18

List of Figures
Inovio Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Inovio Pharmaceuticals Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Inovio Pharmaceuticals Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Inovio Pharmaceuticals Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Inovio Pharmaceuticals Inc (INO):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aethlon Medical Inc (AEMD):医療機器:M&Aディール及び事業提携情報
    Summary Aethlon Medical Inc (Aethlon Medical) is a developer of therapeutic technologies that address unmet needs in biodefense and global health. It develops immunotherapeutic technologies for the treatment of cancer and infectious diseases. The company’s lead product, Hemopurifier, strengthens nat …
  • Joslin Diabetes Center-製薬・医療分野:企業M&A・提携分析
    Summary Joslin Diabetes Center (Joslin) is a healthcare service provider that provides diabetes treatment, research and education services. The centers services include weight management programs, pregnancy program, eye care, diabetes prevention, research, diabetes patient education, adult diabetic …
  • Ascent Solar Technologies Inc (ASTI):電力:M&Aディール及び事業提携情報
    Summary Ascent Solar Technologies, Inc. (Ascent solar) designs, develops and manufactures thin-film photovoltaic modules. It pioneered the thin-film copper-indium-gallium-diselenide (CIGS) photovoltaic technology. The company employs monolithic integration process, which helps improve efficiency and …
  • TES Aviation Group:企業の戦略・SWOT・財務情報
    TES Aviation Group - Strategy, SWOT and Corporate Finance Report Summary TES Aviation Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Atlas Copco AB:企業の戦略・SWOT・財務情報
    Atlas Copco AB - Strategy, SWOT and Corporate Finance Report Summary Atlas Copco AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Stolt-Nielsen Ltd (SNI):石油・ガス:M&Aディール及び事業提携情報
    Summary Stolt-Nielsen Ltd (Stolt-Nielsen) is an integrated global transportation company, which provides bulk-liquid transportation, storage and distribution services. The company operates a fleet of deep-sea, regional, coastal and inland parcel tankers, to offers transportation services to the manu …
  • Raya Holding (RAYA):企業の財務・戦略的SWOT分析
    Raya Holding (RAYA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Elia System Operator SA (ELI):電力:M&Aディール及び事業提携情報
    Summary Elia System Operator SA (Elia) is a transmission system operator. It owns and operates high-voltage electricity transmission systems in Belgium and Germany. The company transmits electricity from generators to distribution system operators and industrial consumers. Elia also imports and expo …
  • BioDelivery Sciences International Inc (BDSI):企業の財務・戦略的SWOT分析
    BioDelivery Sciences International Inc (BDSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Control4 Corp (CTRL):企業の財務・戦略的SWOT分析
    Control4 Corp (CTRL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Sinopharm Group Co Ltd (1099):製薬・医療:M&Aディール及び事業提携情報
    Summary Sinopharm Group Co Ltd (Sinopharm), a subsidiary of China National Pharmaceutical Group Corp is a distributor of pharmaceutical and healthcare products. The group provides distribution, logistics and other value-added services to foreign and domestic manufacturers and suppliers of pharmaceut …
  • Axela Inc-医療機器分野:企業M&A・提携分析
    Summary Axela Inc (Axela), formerly Axela Biosensors Inc is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors and software products. It offers technical and …
  • Leonardo DRS Inc:企業の戦略的SWOT分析
    Leonardo DRS Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • AB Orlen Lietuva:企業の戦略的SWOT分析
    AB Orlen Lietuva - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Ecsponent Ltd (ECS):企業の財務・戦略的SWOT分析
    Ecsponent Ltd (ECS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • The Credit Mutuel-Cic Group:企業の戦略・SWOT・財務分析
    The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report Summary The Credit Mutuel-Cic Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Les Laboratoires Servier SAS:企業の戦略的SWOT分析
    Les Laboratoires Servier SAS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Movado Group, Inc. (MOV):企業の財務・戦略的SWOT分析
    Movado Group, Inc. (MOV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Columbia Power Corp:企業の戦略的SWOT分析
    Columbia Power Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Sunesis Pharmaceuticals Inc (SNSS):製薬・医療:M&Aディール及び事業提携情報
    Summary Sunesis Pharmaceuticals Inc (Sunesis), formerly Mosaic Pharmaceuticals, Inc. develops and markets cancer therapeutics for the treatment of solid and hematologic cancers. The company's Vosaroxin is being developed in Phase III clinical trials for the treatment of acute myeloid leukemia (AML). …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆